• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高截留量膜的定制及其在脓毒症相关性急性肾衰竭中的可行性应用:体外研究

Tailoring high-cut-off membranes and feasible application in sepsis-associated acute renal failure: in vitro studies.

作者信息

Mariano Filippo, Fonsato Valentina, Lanfranco Giacomo, Pohlmeier Robert, Ronco Claudio, Triolo Giorgio, Camussi Giovanni, Tetta Ciro, Passlick-Deetjen Jutta

机构信息

Department of Medicine Area, Nephrology and Dialysis Unit, CTO Hospital, Turin 10126, Italy.

出版信息

Nephrol Dial Transplant. 2005 Jun;20(6):1116-26. doi: 10.1093/ndt/gfh776. Epub 2005 Apr 6.

DOI:10.1093/ndt/gfh776
PMID:15814541
Abstract

BACKGROUND

As removal of pro-inflammatory cytokines is limited in conventional diffusive or convective extracorporeal therapies, we studied in two polysulphone membranes with an industrial albumin sieving coefficient of 0.05 (Type A) and 0.13 (Type B) cytokine (IL-6, IL-8, IL-1beta, IL-1ra, TNF-alpha) and plasma protein (albumin, cystatin C, total proteins) permeability profiles. Based on the convective membrane permeability, we evaluated in vitro the dialytic modality that could provide an acceptable balance between high cytokine and low albumin clearances.

METHODS

Cytokine and plasma protein sieving coefficient (SC) and clearance were studied in (i) post-dilutional haemofiltration mode at 20% fixed ultrafiltration rate; (ii) haemodialysis mode (dialysate flow rate of 3 and 5 l/h); and (iii) haemodiafiltration mode (dialysate flow rate of 3 or 5 l/h with 0.5 l/h of ultrafiltrate).

RESULTS

In haemofiltration mode both Type A and Type B haemodialysers at QB 150 ml/min exhibited similar median SC nearly up to 1 for IL-1beta and IL-1ra, at about 0.6 for IL-6, 0.4 for IL-8 and 0.7 for TNF-alpha, with clearance values ranging from 15 to 30 ml/min. SC were independent of blood flow and were stable throughout the whole experiment. Albumin SC was higher in Type B than in Type A and rapidly decreased from 0.2 to 0.02 and from 0.5 to 0.04 within 3 h for haemodialyser Types A and B, respectively. Cytokine SC was lower in haemodialysis than in haemodiafiltration and haemofiltration mode, and by increasing dialysate flow from 3 up to 5 l/h in both haemodialysis and haemodiafiltration mode, SC for all tested cytokines decreased. However, at 5 l/h clearances were not different or were higher, since increased amounts of dialysate outlet compensated for the decreased SC. Albumin clearances in haemodialysis and haemodiafiltration mode after 360 min at 5 l/h were 0.81 and 0.91 ml/min, respectively.

CONCLUSIONS

Our studies show that a mixed convective and diffusive technique ensures high cytokine clearances with an acceptable loss of albumin.

摘要

背景

由于在传统的扩散或对流体外治疗中,促炎细胞因子的清除有限,我们研究了两种聚砜膜,其工业白蛋白筛选系数分别为0.05(A型)和0.13(B型),观察细胞因子(白细胞介素-6、白细胞介素-8、白细胞介素-1β、白细胞介素-1受体拮抗剂、肿瘤坏死因子-α)和血浆蛋白(白蛋白、胱抑素C、总蛋白)的通透特性。基于对流膜通透性,我们在体外评估了能在高细胞因子清除率和低白蛋白清除率之间提供可接受平衡的透析方式。

方法

在以下情况下研究细胞因子和血浆蛋白的筛选系数(SC)及清除率:(i)后稀释血液滤过模式,固定超滤率为20%;(ii)血液透析模式(透析液流速为3和5 l/h);(iii)血液透析滤过模式(透析液流速为3或5 l/h,超滤率为0.5 l/h)。

结果

在血液滤过模式下,QB为150 ml/min时,A型和B型血液透析器对白细胞介素-1β和白细胞介素-1受体拮抗剂的中位SC几乎高达1,白细胞介素-6约为0.6,白细胞介素-8为0.4,肿瘤坏死因子-α为0.7,清除率值在15至30 ml/min之间。SC与血流量无关,且在整个实验过程中保持稳定。B型的白蛋白SC高于A型,A型和B型血液透析器的白蛋白SC分别在3小时内从0.2迅速降至0.02,从从0.5迅速降至0.04。血液透析模式下细胞因子SC低于血液透析滤过和血液滤过模式,在血液透析和血液透析滤过模式中,将透析液流速从3 l/h提高到5 l/h时,所有测试细胞因子的SC均降低。然而,在5 l/h时清除率无差异或更高,因为透析液流出量的增加弥补了SC的降低。在5 l/h下360分钟后,血液透析和血液透析滤过模式下的白蛋白清除率分别为0.81和0.91 ml/min。

结论

我们的研究表明,对流与扩散相结合的技术可确保高细胞因子清除率,同时白蛋白损失可接受。

相似文献

1
Tailoring high-cut-off membranes and feasible application in sepsis-associated acute renal failure: in vitro studies.高截留量膜的定制及其在脓毒症相关性急性肾衰竭中的可行性应用:体外研究
Nephrol Dial Transplant. 2005 Jun;20(6):1116-26. doi: 10.1093/ndt/gfh776. Epub 2005 Apr 6.
2
TNF-alpha elimination with high cut-off haemofilters: a feasible clinical modality for septic patients?使用高通量血液滤过器清除肿瘤坏死因子-α:脓毒症患者的一种可行临床方式?
Nephrol Dial Transplant. 2003 Jul;18(7):1361-9. doi: 10.1093/ndt/gfg115.
3
Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.血液透析及后稀释血液透析滤过中蛋白结合型尿毒症毒素的清除。
Nephrol Dial Transplant. 2010 Jan;25(1):212-8. doi: 10.1093/ndt/gfp437. Epub 2009 Sep 15.
4
Efficacy of cytokine removal by plasmadiafiltration using a selective plasma separator: in vitro sepsis model.使用选择性血浆分离器通过血浆滤过去除细胞因子的疗效:体外脓毒症模型
Ther Apher Dial. 2011 Feb;15(1):98-108. doi: 10.1111/j.1744-9987.2010.00850.x. Epub 2010 Aug 31.
5
Hemodialysis membrane with a high-molecular-weight cutoff and cytokine levels in sepsis complicated by acute renal failure: a phase 1 randomized trial.具有高分子截留量的血液透析膜与脓毒症合并急性肾衰竭时的细胞因子水平:一项1期随机试验
Am J Kidney Dis. 2007 Aug;50(2):296-304. doi: 10.1053/j.ajkd.2007.05.003.
6
Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure.脓毒症合并急性肾衰竭患者持续高通量血液透析期间的肿瘤坏死因子-α
Kidney Int Suppl. 1999 Nov(72):S84-7.
7
Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.低透析液流速下小溶质的透析器清除率和传质面积系数。
ASAIO J. 2006 Jul-Aug;52(4):404-9. doi: 10.1097/01.mat.0000227687.88929.08.
8
In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes.采用丙烯腈和聚砜膜连续肾脏替代疗法对依诺肝素清除的体外和体内评估。
Clin Ther. 2005 Sep;27(9):1444-51. doi: 10.1016/j.clinthera.2005.09.008.
9
Effects of a polyelectrolyte additive on the selective dialysis membrane permeability for low-molecular-weight proteins.聚电解质添加剂对低分子量蛋白质选择性透析膜通透性的影响。
Nephrol Dial Transplant. 2007 Feb;22(2):491-9. doi: 10.1093/ndt/gfl610. Epub 2006 Oct 18.
10
[The protective effects to the function of kidney and long by clearing of cytokines in patients with open-heart surgery].[通过清除心脏直视手术患者细胞因子对肾脏和肺部功能的保护作用]
Zhonghua Yi Xue Za Zhi. 2005 Nov 30;85(45):3194-8.

引用本文的文献

1
Continuous Renal Replacement Therapy: Forty-year Anniversary.连续性肾脏替代治疗:四十周年纪念
Int J Artif Organs. 2017 Jun;40(6):257-264. doi: 10.5301/ijao.5000610.
2
Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.重症监护病房中的急性肾损伤:从损伤到恢复:第五届巴黎国际会议报告
Ann Intensive Care. 2017 Dec;7(1):49. doi: 10.1186/s13613-017-0260-y. Epub 2017 May 4.
3
Effectiveness of High Cut-Off Hemofilters in the Removal of Selected Cytokines in Patients During Septic Shock Accompanied by Acute Kidney Injury-Preliminary Study.
高截留量血液滤过器对伴有急性肾损伤的感染性休克患者特定细胞因子的清除效果——初步研究
Med Sci Monit. 2016 Nov 13;22:4338-4344. doi: 10.12659/MSM.896819.
4
Recent evolution of renal replacement therapy in the critically ill patient.危重症患者肾脏替代治疗的最新进展。
Crit Care. 2006 Feb;10(1):123. doi: 10.1186/cc4843.